The FDA accepted Pfizer's biologics license application for its pentavalent meningococcal vaccine candidate intended for people between the ages of 10 and 25. 

Since 2019, the FDA has reported dozens of drug recalls because of the presence of nitrosamine, a probable carcinogen that largely pulls blood pressure treatments off the market. 

India-based drugmaker Aurobindo Pharma received a tentative approval from the FDA for its dimethyl fumarate capsules to treat multiple sclerosis, CNBC reported Dec. 27. 

Nearly a year after launching the online pharmacy Mark Cuban Cost Plus Drug Co., the company has hundreds of generics, more than 1 million customers, and partnerships with pharmacy benefit managers and payers. 

Congress passed an end-of-year bill Dec. 23 that includes withdrawing a federal barrier to pharmacists prescribing an opioid overdose treatment and numerous strategies to manage persistent drug supply problems. 

The so-called morning after pill, Plan B One-Step (and generic versions of the drug, levonorgestrel), does not cause abortions, the FDA confirmed Dec. 23, despite packaging information that suggests otherwise.

Sunlenca, a new HIV drug for patients with limited available treatment options, was approved Dec. 22 by the FDA. The new drug is an option for adults with HIV who cannot tolerate, are resistant to or have safety issues with other established treatments for the disease.

Wisconsin hospitals and pharmacies are limiting their Tamiflu prescriptions in the face of severe shortages, NBC affiliate WMTV reported Dec. 20.

A third death has been tied to experimental Alzheimer's drug lecanemab, amplifying concerns about its safety, Science reported Dec. 21.

The FDA approved Roche's monoclonal antibody to treat COVID-19 Dec. 21, about three weeks after the agency reversed its authorization for Eli Lilly's monoclonal drug. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Hospitals are failing to fulfill the promise of the 340B program, which offers discounted drugs to hospitals that treat a large proportion of underinsured and uninsured patients, The Wall Street Journal reported Dec. 20. 

As demand for a popular flu drug increases during the worst flu season in more than a decade, HHS expanded access to Tamiflu on Dec. 21 through the Strategic National Stockpile. 

As drugmakers prepare for the government to stop paying for their COVID-19 treatments, the value of Pfizer's popular COVID-19 drug Paxlovid has decreased by more than 80 percent, according to the Institute for Clinical and Economic Review. 

From its plan to acquire Summit Health to its robot-powered fulfillment centers, and from its $5 billion settlement for opioid cases to reforming its worker evaluation practices, here are Walgreens' biggest moves in 2022 listed in order of Becker's coverage. 

Chantal Friebertshäuser, a former executive at Merck and Eli Lilly, will join Moderna as the senior vice president of commercial, Europe, Middle East and Canada, effective Jan. 1. 

Pharmacists will be listed as providers on some U.S. government employees' insurance bills for their roles in assessing COVID-19 symptoms and prescribing the antiviral Paxlovid. 

The two largest pharmacy retailers are restricting orders for some pediatric pain medications as healthcare battles a strong season of flu, respiratory syncytial virus and COVID-19 cases, The Hill reported Dec. 19. 

The Drug Enforcement Administration may revoke TruePill's ability to fill controlled substances over allegations that it wrongly filled thousands of prescriptions for stimulants used to treat attention-deficit/hyperactivity disorder. 

The FDA added Eli Lilly's diabetes drugs Mounjaro and Trulicity to its list of medications in short supply Dec. 15.